Cancer Immunotherapy Market Forecast, Trend Analysis & Competition Tracking - Global Market Insights 2021 to 2031

Oct 2021| FMR570B| Fact Market Research

Report Highlights

Cancer Immunotherapy Market- Scope of Report

A recent study by Fact.MR on the cancer immunotherapy market offers a 10-year forecast for 2021 to 2031. The study analyzes crucial trends that are currently determining the growth of the market. This report explicates on vital dynamics, such as the drivers, restraints, and opportunities for key market players along with key stakeholders as well as emerging players associated with offering cancer immunotherapy.

The study also provides the dynamics responsible for influencing the future status of the cancer immunotherapy market over the forecast period. A detailed assessment of value chain analysis, business execution, and supply chain analysis across regional markets has been covered in the report. A list of prominent companies operating in the cancer immunotherapy market, along with their product portfolios, enhances the reliability of this comprehensive research study.

Report Summary

The study offers comprehensive analysis on diverse features, including production capacities, demand, product developments, revenue generation, and sales of cancer immunotherapy across the globe.

A comprehensive estimate on the market has been provided through an optimistic as well as a conservative scenario, taking into account the sales of cancer immunotherapy during the forecast period. Price point comparison by region with global average price is also considered in the study.

Key Questions Answered in Report

  • Which are the most lucrative cancer immunotherapy markets?
  • Which factors will impact the growth of cancer immunotherapy?
  • How will changing trends impact the strategies of market players?
  • How can market players capture the low-hanging opportunities across regions?
  • Which companies are leading the cancer immunotherapy industry?
  • What are the winning strategies of stakeholders in the market?

Analysis on Market Size Evaluation

The market has been analyzed for each segment in terms of volume (‘000 Units) and value (US$ Mn).

Estimates at global and regional levels for cancer immunotherapy are available in terms of “US$ Mn” for value and in “‘000 Units” for volume. A Y-o-Y growth contrast on prominent market segments, along with market attractiveness evaluation, has been incorporated in the report. Furthermore, absolute dollar opportunity analysis of all the segments adds prominence to the report.

Absolute dollar opportunity plays a crucial role in assessing the level of opportunity that a manufacturer/distributor can look to achieve, along with identifying potential resources, considering the sales and distribution perspective in the global cancer immunotherapy market.

Inspected Assessment on Regional Segments

Key sections have been elaborated in the report, which have helped deliver projections on regional markets. These chapters include regional macros (political, economic, and business environment outlook), which are expected to have a momentous influence on the growth of the cancer immunotherapy market during the forecast period.

Country-specific valuation on demand for cancer immunotherapy has been offered for each region, along with market scope estimates and forecasts, price index, and impact analysis of the dynamics of prominence in regions and countries. For all regional markets, Y-o-Y growth estimates have also been incorporated in the report.

Detailed breakup in terms of value & volume for emerging countries has also been included in the report.

In-depth Analysis on Competition Analysis

The report sheds light on leading manufacturers of cancer immunotherapy, along with their detailed profiles. Essential and up-to-date data related to market performers who are principally engaged in offering cancer immunotherapy has been brought with the help of a detailed dashboard view. Market share analysis and comparison of prominent players provided in the report permits report readers to take preemptive steps in advancing their businesses.

Company profiles have been included in the report, which include essentials such as product portfolios and key strategies, along with all-inclusive SWOT analysis on each player. Company presence is mapped and presented through a matrix for all the prominent players, thus providing readers with actionable insights, which helps in thoughtfully presenting the market status, and predicting the competition level in the cancer immunotherapy domain.

Research Methodology

In Fact.MR’s study, a unique research methodology is utilized to conduct extensive research on the growth of the cancer immunotherapy industry, and reach conclusions on the future growth parameters. This research methodology is a combination of primary and secondary research, which helps analysts ensure the accuracy and reliability of the drawn conclusions.

Secondary resources referred to by analysts during the preparation of the market study include statistics from governmental organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, all of whom have contributed to the development of the research report as a primary resource.

  • Table 1 : Global Cancer Immunotherapy Market Size (US$ Mn) Forecast, by Therapy Type, 2021–2031
  • Table 2 : Global Cancer Immunotherapy Market Size (US$ Mn) Forecast, By Therapy Type (Immune Checkpoint Inhibitors), 2021–2031
  • Table 3 : Global Cancer Immunotherapy Market Size (US$ Mn) Forecast, by Therapeutic Area, 2021–2031
  • Table 4 : Global Cancer Immunotherapy Market Size (US$ Mn) Forecast, by End-User, 2021–2031
  • Table 5 : Global Cancer Immunotherapy Market Size (US$ Mn) Forecast, by Region, 2021–2031
  • Table 6 : North America Cancer Immunotherapy Market Size (US$ Mn) Forecast, by Therapy Type, 2021–2031
  • Table 7 : North America Cancer Immunotherapy Market Size (US$ Mn) Forecast, by Therapy Type (Immune Checkpoint Inhibitors), 2021–2031
  • Table 8 : North America Cancer Immunotherapy Market Size (US$ Mn) Forecast, by Therapeutic Area, 2021–2031
  • Table 9 : North America Cancer Immunotherapy Market Size (US$ Mn) Forecast, by End-User, 2021–2031
  • Table 10 : North America Cancer Immunotherapy Market Size (US$ Mn) Forecast, by Country, 2021–2031
  • Table 11 : Europe Cancer Immunotherapy Market Size (US$ Mn) Forecast, by Therapy Type, 2021–2031
  • Table 12 : Europe Cancer Immunotherapy Market Size (US$ Mn) Forecast, by Therapy Type (Immune Checkpoint Inhibitors), 2021–2031
  • Table 13 : Europe Cancer Immunotherapy Market Size (US$ Mn) Forecast, by Therapeutic Area, 2021–2031
  • Table 14 : Europe Cancer Immunotherapy Market Size (US$ Mn) Forecast, by End-User, 2021–2031
  • Table 15 : Europe Cancer Immunotherapy Market Size (US$ Mn) Forecast, by Country, 2021–2031
  • Table 16 : Asia Pacific Cancer Immunotherapy Market Size (US$ Mn) Forecast, by Therapy Type, 2021–2031
  • Table 17 : Asia Pacific Cancer Immunotherapy Market Size (US$ Mn) Forecast, by Therapy Type (Immune Checkpoint Inhibitors), 2021–2031
  • Table 18 : Asia Pacific Cancer Immunotherapy Market Size (US$ Mn) Forecast, by Therapeutic Area, 2021–2031
  • Table 19 : Asia Pacific Cancer Immunotherapy Market Size (US$ Mn) Forecast, by End-User, 2021–2031
  • Table 20 : Asia Pacific Cancer Immunotherapy Market Size (US$ Mn) Forecast, by Country, 2021–2031
  • Table 21 : Latin America Cancer Immunotherapy Market Size (US$ Mn) Forecast, by Therapy Type, 2021–2031
  • Table 22 : Latin America Cancer Immunotherapy Market Size (US$ Mn) Forecast, by Therapy Type (Immune Checkpoint Inhibitors), 2021–2031
  • Table 23 : Latin America Cancer Immunotherapy Market Size (US$ Mn) Forecast, by Therapeutic Area, 2021–2031
  • Table 24 : Latin America Cancer Immunotherapy Market Size (US$ Mn) Forecast, by End-User, 2021–2031
  • Table 25 : Latin America Cancer Immunotherapy Market Size (US$ Mn) Forecast, by Country, 2021–2031
  • Table 26 : Middle East & Africa Cancer Immunotherapy Market Size (US$ Mn) Forecast, by Therapy Type, 2021–2031
  • Table 27 : Middle East & Africa Cancer Immunotherapy Market Size (US$ Mn) Forecast, by Therapy Type (Immune Checkpoint Inhibitors), 2021–2031
  • Table 28 : Middle East & Africa Cancer Immunotherapy Market Size (US$ Mn) Forecast, by End-User, 2021–2031
  • Table 29 : Middle East & Africa Cancer Immunotherapy Market Size (US$ Mn) Forecast, by Country, 2021–2031
  • Figure 1 : Global Cancer Immunotherapy Market Size (US$ Mn) Forecast, 2021–2031
  • Figure 2 : Global Cancer Immunotherapy Market Value Share Analysis, by Therapy Type, 2021 and 2031
  • Figure 3 : Global Cancer Immunotherapy Market Revenue (US$ Mn) and Y-o-Y growth (%), By Monoclonal Antibodies, 2021–2031
  • Figure 4 : Global Cancer Immunotherapy Market Revenue (US$ Mn) and Y-o-Y growth (%), By Immune Checkpoint Inhibitors, 2021–2031
  • Figure 5 : Global Cancer Immunotherapy Market Revenue (US$ Mn) and Y-o-Y growth (%), By Immune System Modulators, 2021–2031
  • Figure 6 : Global Cancer Immunotherapy Market Revenue (US$ Mn) and Y-o-Y growth (%), By Cancer Vaccines, 2021–2031
  • Figure 7 : Global Cancer Immunotherapy Market Revenue (US$ Mn) and Y-o-Y growth (%), By Others, 2021–2031
  • Figure 8 : Global Cancer Immunotherapy Market Attractiveness Analysis, by Therapy Type
  • Figure 9 : Global Cancer Immunotherapy Market Revenue (US$ Mn) and Y-o-Y growth (%), By PD-1/PD-L1 Type, 2021–2031
  • Figure 10 : Global Cancer Immunotherapy Market Revenue (US$ Mn) and Y-o-Y growth (%), By CTLA-4 Type, 2021–2031
  • Figure 11 : Global Cancer Immunotherapy Market Attractiveness Analysis, by Therapy Type (Immune Checkpoint Inhibitors)
  • Figure 12 : Global Cancer Immunotherapy Market Value Share Analysis, by Therapeutic Area, 2021 and 2031
  • Figure 13 : Global Cancer Immunotherapy Market Attractiveness Analysis, by Therapeutic Area
  • Figure 14 : Global Cancer Immunotherapy Market Revenue (US$ Mn) and Y-o-Y growth (%), By Lung Cancer, 2021–2031
  • Figure 15 : Global Cancer Immunotherapy Market Revenue (US$ Mn) and Y-o-Y growth (%), By Colorectal Cancer, 2021–2031
  • Figure 16 : Global Cancer Immunotherapy Market Revenue (US$ Mn) and Y-o-Y growth (%), By Breast Cancer, 2021–2031
  • Figure 17 : Global Cancer Immunotherapy Market Revenue (US$ Mn) and Y-o-Y growth (%), By Prostate Cancer, 2021–2031
  • Figure 18 : Global Cancer Immunotherapy Market Revenue (US$ Mn) and Y-o-Y growth (%), By Melanoma, 2021–2031
  • Figure 19 : Global Cancer Immunotherapy Market Revenue (US$ Mn) and Y-o-Y growth (%), By Blood Cancers, 2021–2031
  • Figure 20 : Global Cancer Immunotherapy Market Revenue (US$ Mn) and Y-o-Y growth (%), By Other Cancers, 2021–2031
  • Figure 21 : Global Cancer Immunotherapy Market Value Share Analysis, by End-User, 2021 and 2031
  • Figure 22 : Global Cancer Immunotherapy Market Revenue (US$ Mn) and Y-o-Y growth (%), By Hospitals, 2021–2031
  • Figure 23 : Global Cancer Immunotherapy Market Revenue (US$ Mn) and Y-o-Y growth (%), By ASC’s, 2021–2031
  • Figure 24 : Global Cancer Immunotherapy Market Revenue (US$ Mn) and Y-o-Y growth (%), By Cancer Research Institutes, 2021–2031
  • Figure 25 : Global Cancer Immunotherapy Market Revenue (US$ Mn) and Y-o-Y growth (%), By Clinics, 2021–2031
  • Figure 26 : Global Cancer Immunotherapy Market Attractiveness Analysis, by End-User
  • Figure 27 : Global Cancer Immunotherapy Market Value Share Analysis, by Region, 2021 and 2031
  • Figure 28 : Global Cancer Immunotherapy Market Attractiveness Analysis, by Region
  • Figure 29 : North America Cancer Immunotherapy Market Size (US$ Mn) Forecast, 2021–2031
  • Figure 30 : North America Cancer Immunotherapy Market Attractiveness Analysis By Country
  • Figure 31 : North America Market Value Share Analysis, by Therapy Type, 2021 and 2031
  • Figure 32 : North America Market Value Share Analysis, by Therapeutic Area, 2021 and 2031
  • Figure 33 : North America Market Value Share Analysis, by End-User, 2021 and 2031
  • Figure 34 : North America Market Value Share Analysis, by Country, 2021 and 2031
  • Figure 35 : U.S. Cancer Immunotherapy Market Size (US$ Mn) Forecast, 2021–2031
  • Figure 36 : U.S. Cancer Immunotherapy Market Absolute $ Opportunity (US$ Mn), 2021–2031
  • Figure 37 : Canada Cancer Immunotherapy Market Size (US$ Mn) Forecast, 2021–2031
  • Figure 38 : Canada Cancer Immunotherapy Market Absolute $ Opportunity (US$ Mn), 2021–2031
  • Figure 39 : North America Cancer Immunotherapy Market Attractiveness by Therapy Type
  • Figure 40 : North America Cancer Immunotherapy Market Attractiveness by Therapeutic Area
  • Figure 41 : North America Cancer Immunotherapy Market Attractiveness by End-User
  • Figure 42 : Europe Cancer Immunotherapy Market Size (US$ Mn) Forecast, 2021–2031
  • Figure 43 : Europe Cancer Immunotherapy Market Attractiveness Analysis by Country
  • Figure 44 : Europe Cancer Immunotherapy Market Value Share Analysis, by Therapy Type, 2021 and 2031
  • Figure 45 : Europe Cancer Immunotherapy Market Value Share Analysis, by Therapeutic Area, 2021 and 2031
  • Figure 46 : Europe Cancer Immunotherapy Market Value Share Analysis, by End-User, 2021 and 2031
  • Figure 47 : Europe Cancer Immunotherapy Market Value Share Analysis, by Country, 2021 and 2031
  • Figure 48 : Germany Cancer Immunotherapy Market Size (US$ Mn) Forecast, 2021–2031
  • Figure 49 : Germany Cancer Immunotherapy Market Absolute $ Opportunity (US$ Mn), 2021–2031
  • Figure 50 : U.K. Cancer Immunotherapy Market Size (US$ Mn) Forecast, 2021–2031
  • Figure 51 : U.K. Cancer Immunotherapy Market Absolute $ Opportunity (US$ Mn), 2021–2031
  • Figure 52 : France Cancer Immunotherapy Market Size (US$ Mn) Forecast, 2021–2031
  • Figure 53 : France Cancer Immunotherapy Market Absolute $ Opportunity (US$ Mn), 2021–2031
  • Figure 54 : Spain Cancer Immunotherapy Market Size (US$ Mn) Forecast, 2021–2031
  • Figure 55 : Spain Cancer Immunotherapy Market Absolute $ Opportunity (US$ Mn), 2021–2031
  • Figure 56 : Italy Cancer Immunotherapy Market Size (US$ Mn) Forecast, 2021–2031
  • Figure 57 : Italy Cancer Immunotherapy Market Absolute $ Opportunity (US$ Mn), 2021–2031
  • Figure 58 : Rest of Europe Cancer Immunotherapy Market Size (US$ Mn) Forecast, 2021–2031
  • Figure 59 : Rest of Europe Cancer Immunotherapy Market Absolute $ Opportunity (US$ Mn), 2021–2031
  • Figure 60 : Europe Cancer Immunotherapy Market Attractiveness by Therapy Type
  • Figure 61 : Europe Cancer Immunotherapy Market Attractiveness by Therapeutic Area
  • Figure 62 : Europe Cancer Immunotherapy Market Attractiveness by End-User
  • Figure 63 : Asia Pacific Cancer Immunotherapy Market Size (US$ Mn) Forecast, 2021–2031
  • Figure 64 : Asia Pacific Cancer Immunotherapy Market Attractiveness Analysis, By Country
  • Figure 65 : Asia Pacific Cancer Immunotherapy Market Value Share Analysis, by Therapy Type, 2021 and 2031
  • Figure 66 : Asia Pacific Cancer Immunotherapy Market Value Share Analysis, by End-User, 2021 and 2031
  • Figure 67 : Asia Pacific Cancer Immunotherapy Market Value Share Analysis, by Country, 2021 and 2031
  • Figure 68 : Japan Cancer Immunotherapy Market Size (US$ Mn) Forecast, 2021–2031
  • Figure 69 : Japan Cancer Immunotherapy Market Absolute $ Opportunity (US$ Mn), 2021–2031
  • Figure 70 : China Cancer Immunotherapy Market Size (US$ Mn) Forecast, 2021–2031
  • Figure 71 : China Cancer Immunotherapy Market Absolute $ Opportunity (US$ Mn), 2021–2031
  • Figure 72 : India Cancer Immunotherapy Market Size (US$ Mn) Forecast, 2021–2031
  • Figure 73 : India Cancer Immunotherapy Market Absolute $ Opportunity (US$ Mn), 2021–2031
  • Figure 74 : Australia Cancer Immunotherapy Market Size (US$ Mn) Forecast, 2021–2031
  • Figure 75 : Australia Cancer Immunotherapy Market Absolute $ Opportunity (US$ Mn), 2021–2031
  • Figure 76 : New Zealand Cancer Immunotherapy Market Size (US$ Mn) Forecast, 2021–2031
  • Figure 77 : New Zealand Cancer Immunotherapy Market Absolute $ Opportunity (US$ Mn), 2021–2031
  • Figure 78 : Rest of Asia Pacific Cancer Immunotherapy Market Size (US$ Mn) Forecast, 2021–2031
  • Figure 79 : Rest of Asia Pacific Cancer Immunotherapy Market Absolute $ Opportunity (US$ Mn), 2021–2031
  • Figure 80 : Asia Pacific Cancer Immunotherapy Market Attractiveness by Therapy Type
  • Figure 81 : Asia Pacific Cancer Immunotherapy Market Attractiveness by Therapeutic Area
  • Figure 82 : Asia Pacific Cancer Immunotherapy Market Attractiveness by End-User
  • Figure 83 : Latin America Cancer Immunotherapy Market Attractiveness Analysis by Country
  • Figure 84 : Latin America Cancer Immunotherapy Market Value Share Analysis, by Therapy Type, 2021 and 2031
  • Figure 85 : Latin America Cancer Immunotherapy Market Value Share Analysis, by Therapeutic Area, 2021 and 2031
  • Figure 86 : Latin America Cancer Immunotherapy Market Value Share Analysis, by End-User, 2021 and 2031
  • Figure 87 : Latin America Cancer Immunotherapy Market Value Share Analysis, by Country, 2021 and 2031
  • Figure 88 : Brazil Cancer Immunotherapy Market Size (US$ Mn) Forecast, 2021–2031
  • Figure 89 : Brazil Cancer Immunotherapy Market Absolute $ Opportunity (US$ Mn), 2021–2031
  • Figure 90 : Mexico Cancer Immunotherapy Market Size (US$ Mn) Forecast, 2021–2031
  • Figure 91 : Mexico Cancer Immunotherapy Market Absolute $ Opportunity (US$ Mn), 2021–2031
  • Figure 92 : Rest of Latin America Cancer Immunotherapy Market Absolute $ Opportunity (US$ Mn), 2021–2031
  • Figure 93 : Latin America Cancer Immunotherapy Market Attractiveness by Therapy Type
  • Figure 94 : Latin America Cancer Immunotherapy Market Attractiveness by Therapeutic Area
  • Figure 95 : Latin America Cancer Immunotherapy Market Attractiveness by End-User
  • Figure 96 : Middle East & Africa Cancer Immunotherapy Market Size (US$ Mn) Forecast, 2021–2031
  • Figure 97 : Middle East & Africa Cancer Immunotherapy Market Attractiveness Analysis by Country
  • Figure 98 : Middle East & Africa Cancer Immunotherapy Market Value Share Analysis, by Therapy Type, 2021 and 2031
  • Figure 99 : Middle East & Africa Cancer Immunotherapy Market Value Share Analysis, by Therapeutic Area, 2021 and 2031
  • Figure 100 : Middle East & Africa Cancer Immunotherapy Market Value Share Analysis, by End-User, 2021 and 2031
  • Figure 101 : Saudi Arabia Cancer Immunotherapy Market Size (US$ Mn) Forecast, 2021–2031
  • Figure 102 : Saudi Arabia Cancer Immunotherapy Market Absolute $ Opportunity (US$ Mn), 2021–2031
  • Figure 103 : UAE Cancer Immunotherapy Market Size (US$ Mn) Forecast, 2021–2031
  • Figure 104 : UAE Cancer Immunotherapy Market Absolute $ Opportunity (US$ Mn), 2021–2031
  • Figure 105 : RSA Cancer Immunotherapy Market Size (US$ Mn) Forecast, 2021–2031
  • Figure 106 : RSA Cancer Immunotherapy Market Absolute $ Opportunity (US$ Mn), 2021–2031
  • Figure 107 : Rest of Middle East & Africa Cancer Immunotherapy Market Size (US$ Mn) Forecast, 2021–2031
  • Figure 108 : Rest of Middle East & Africa Cancer Immunotherapy Market Absolute $ Opportunity (US$ Mn), 2021–2031
  • Figure 109 : Middle East & Africa Cancer Immunotherapy Market Attractiveness by Therapy Type
  • Figure 110 : Middle East & Africa Cancer Immunotherapy Market Attractiveness by Therapeutic Area
  • Figure 111 : Middle East & Africa Cancer Immunotherapy Market Attractiveness by End-User

Fact.MR is an independent, pure play market intelligence firm incorporated with an objective to deliver high quality, customized market research solutions that help our clients successfully go to the market equipped with actionable insights capable of impacting crucial business decisions.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

Contact Us
RELATED REPORTS
Share This Report